I’m not sure what age people begin to care about the lives of birds, but I think I’ve reached that point. I’m not quite at the stage where I name […] The post Life with MS has given me a new complex to worry about appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Category: Multiple Sclerosis Research
ECTRIMS 2025: Ocrevus as good as Gilenya for treating MS in children
Children and adolescents living with multiple sclerosis (MS) seem to benefit at least as much — and for some outcomes, significantly more — from Ocrevus (ocrelizumab) as from treatment with […] The post ECTRIMS 2025: Ocrevus as good as Gilenya for treating MS in children appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Gone
Tweet This week at ECTRIMS 2025 I understand that Biogen did not have a major presence…Have they dumped MS to focus elsewhere. However they have reported a natalizumab v2.0. It is a another humanised antibody. But why bother I wondered what advantage does it have, natalizumab is given at 300mg i.v. every 4 weeks but…
Menopause is not a risk for progression according to MSBase
Tweet I am not commenting on this you may be interested in the take home message. Bridge F, Sanfilippo PG, Zhu C, Skibina O, Nguyen AL, Kalincik T, Buzzard K, Taylor BV, MacIntyre J, Hall LA, Slee M, Macdonell R, Maltby V, Lechner-Scott J, McCombe P, Butzkueven H, van der Walt A, Jokubaitis VG. Menopause…
ECTRIMS 2025: Frexalimab shows long-term benefits for MS patients
Frexalimab, a therapy Sanofi is developing for multiple sclerosis (MS) patients, led to sustained reductions in disease activity in people with relapsing forms of MS over more than two years […] The post ECTRIMS 2025: Frexalimab shows long-term benefits for MS patients appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ECTRIMS 2025: Ultra-processed foods may fuel disease in early MS
Consuming large amounts of ultra-processed foods (UPF) — products high in additives, artificial ingredients, and extensive processing — is associated with increased disease activity in people with clinically isolated syndrome […] The post ECTRIMS 2025: Ultra-processed foods may fuel disease in early MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Amanda Chavez – MSAA’s October 2025 Artist of the Month
MSAA features the work of many talented artists affected by multiple sclerosis as part of our annual MSAA Art Showcase. Each month we share these artists’ inspiring stories and beautiful artwork with you as our Artist of the Month. This month, we celebrate Amanda … Continue reading → Source: blog.mymsaa.org
Q&A October
Tweet Have any questions? Source: multiple-sclerosis-research.org
ECTRIMS 2025: Eque-cel shown to ease disability in progressive MS
Treatment with equecabtagene autoleucel, known for short as eque-cel — Iaso Biotherapeutics‘ CAR T-cell therapy candidate for people with progressive forms of multiple sclerosis (MS) — was well tolerated and […] The post ECTRIMS 2025: Eque-cel shown to ease disability in progressive MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ECTRIMS 2025: Drug combo shows promise for myelin repair in trial
Combining the diabetes medication metformin and the antihistamine clemastine significantly increased myelin repair in people with relapsing-remitting multiple sclerosis (RRMS), according to results from a Phase 2 clinical trial. However, […] The post ECTRIMS 2025: Drug combo shows promise for myelin repair in trial appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com